GLP-1 Semaglutide Programme

Bay Aesthetics Clinic MediSpa's GLP-1 semaglutide programme provides access to the latest generation of metabolic and weight-management medications under the direct supervision of Dr Bernard Tan and the clinic's medical team. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the body's natural satiety hormone, reducing appetite, slowing gastric emptying and regulating blood glucose — producing sustained weight loss that is…

The weekly injectable formulations — Ozempic (approved for type 2 diabetes management) and WeGovy (approved for chronic weight management) — are administered via a small subcutaneous pen injection once weekly, making them convenient for busy professionals. The dose is titrated gradually over the initial weeks (starting at 0.25mg weekly) to minimise gastrointestinal side effects such as nausea, vomiting and bloating, which typically diminish as the body…

For patients who prefer oral medication, Rybelsus (oral semaglutide 3mg, 7mg or 14mg) is taken once daily on an empty stomach at least 30 minutes before food or other medications. While oral bioavailability is lower than the injectable form, Rybelsus provides meaningful improvements in blood glucose control and modest weight reduction for patients with mild-to-moderate metabolic concerns.